Breaking News Instant updates and real-time market news.

BID

Sotheby's

$50.51

0.97 (1.96%)

11:21
05/19/17
05/19
11:21
05/19/17
11:21

Sotheby's rises after Basquiat painting sets new record

Shares of art auctioneer Sotheby's (BID) are trading higher after the company auctioned off a work of art by painter Jean-Michel Basquiat for a record $110.5M. WHAT'S NEW: The 1982 Basquiat painting, called "Untitled," was bought by Japanese billionaire and Zozotown founder Yusaku Maezawa after just ten minutes of bidding, Sotheby's said. The painting surpassed the previous record for a work by a U.S. artist at auction, which was $105.4M paid for Andy Warhol's "Silver Car Crash (Double Disaster)." Sotheby's said "Untitled" was a critical landmark in Basquiat's career because it "declared the arrival of the brilliant, then virtually unknown young artist into a world that would be forever transformed by his paintings." WHAT'S NOTABLE: Sotheby's announced earlier this week that it sold a pair of diamond earrings for $57.4M, making the set the most expensive earrings ever sold at auction. The set consists of the 14.54-carat "Apollo Blue" earring, which sold for $42.1M, and the 16-carat "Artemis Pink" diamond, which brought in $15.3M. Tad Smith, Sotheby's chief executive officer, suggested earlier this month that fine art prices have room to grow based on the spending power of the world's billionaires, CNBC reported. PRICE ACTION: Shares of Sotheby's rose nearly 2% to $50.40 in late morning trading.

  • 22

    May

BID Sotheby's
$50.51

0.97 (1.96%)

02/28/17
CHLM
02/28/17
NO CHANGE
Target $44
CHLM
Hold
Sotheby's price target raised to $44 from $35 at Craig-Hallum
Craig-Hallum analyst George Sutton raised his price target for Sotheby's to $44 from $35 after the company wrapped up a productive 2016 with a "solid Q4 print," with in-line earnings and revenues that exceeded estimates driven primarily by continued improvement in auction commission margins. He reiterates a Hold rating on the shares.
12/23/16
SIDC
12/23/16
INITIATION
Target $54
SIDC
Buy
Sotheby's initiated with a Buy at Sidoti
Sidoti initiated Sotheby's with a Buy and a $54 price target.
12/16/16
12/16/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Eli Lilly (LLY) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst David Risinger saying he expects shares to outperform driven by new product growth. 2. General Electric (GE) upgraded to Outperform from Market Perform at Bernstein with analyst Steven Winoker citing valuation and his belief that the company has multiple positive catalysts. 3. Clorox (CLX) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Dara Mohsenian saying valuation is somewhat more compelling given recent underperformance while organic sales growth has improved and potential tax policy changes should be beneficial. 4. ADP (ADP) was upgraded to Conviction Buy from Neutral at Goldman while the firm upgraded Paychex (PAYX) to Buy from Neutral. 5. Sotheby's (BID) upgraded to Outperform from Market Perform at Cowen with analyst Oliver Chen saying he believes the company's transformation under new management is in the early innings and likely to gain momentum next year. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/16/16
12/16/16
UPGRADE
Target $45

Outperform
Sotheby's upgraded to Outperform on turnaround progress at Cowen
As previously reported, Cowen analyst Oliver Chen upgraded Sotheby's to Outperform from Market Perform, as he believes the company's transformation under new management is in the early innings and likely to gain momentum next year. Chen, who said better sell-through rates indicate that current demand is healthy, raised his price target on Sotheby's shares to $45 from $38.

TODAY'S FREE FLY STORIES

SVU

Supervalu

$3.25

-0.01 (-0.31%)

06:32
07/25/17
07/25
06:32
07/25/17
06:32
Earnings
Supervalu reports Q1 adjusted EPS 9c, consensus 11c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

MORE

Monogram Residential Trust

$11.95

0.01 (0.08%)

06:32
07/25/17
07/25
06:32
07/25/17
06:32
Downgrade
Monogram Residential Trust rating change  »

Monogram Residential…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PHM

PulteGroup

$24.42

0.11 (0.45%)

06:32
07/25/17
07/25
06:32
07/25/17
06:32
Earnings
PulteGroup reports Q2 adjusted EPS 47c, consensus 41c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

TEAM

Atlassian

$36.41

0.66 (1.85%)

06:31
07/25/17
07/25
06:31
07/25/17
06:31
Upgrade
Atlassian rating change  »

Atlassian upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

BIIB

Biogen

$284.70

1.78 (0.63%)

06:31
07/25/17
07/25
06:31
07/25/17
06:31
Earnings
Biogen reports Q2 adjusted EPS $5.04, consensus $4.41 »

Reports Q2 revenue $3.1B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 01

    Aug

GOOG

Alphabet

$980.34

7.42 (0.76%)

, GOOGL

Alphabet Class A

$998.31

4.47 (0.45%)

06:30
07/25/17
07/25
06:30
07/25/17
06:30
Recommendations
Alphabet, Alphabet Class A analyst commentary  »

Alphabet earnings…

GOOG

Alphabet

$980.34

7.42 (0.76%)

GOOGL

Alphabet Class A

$998.31

4.47 (0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$84.74

0.08 (0.09%)

06:30
07/25/17
07/25
06:30
07/25/17
06:30
Hot Stocks
Eli Lilly will pursue new standard-of-care changing therapies in oncology »

Eli Lilly is providing an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 11

    Sep

LLY

Eli Lilly

$84.74

0.08 (0.09%)

06:29
07/25/17
07/25
06:29
07/25/17
06:29
Earnings
Eli Lilly raises FY17 EPS view to $4.10-$4.20 from $4.05-$4.15, consensus $4.12 »

Raises FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 11

    Sep

DDAIF

Daimler AG

$71.00

-1.9399 (-2.66%)

, BMWYY

BMW

$30.72

-0.8 (-2.54%)

06:28
07/25/17
07/25
06:28
07/25/17
06:28
Periodicals
Daimler directors to discuss alleged German auto cartel, Reuters says »

Daimler's (DDAIF)…

DDAIF

Daimler AG

$71.00

-1.9399 (-2.66%)

BMWYY

BMW

$30.72

-0.8 (-2.54%)

VLKAY

Volkswagen

$32.19

-0.79 (-2.40%)

POAHY

Porsche

$5.82

-0.03 (-0.51%)

AUDVF

Audi AG

$835.60

-4.8 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WERN

Werner

$29.20

-0.35 (-1.18%)

06:28
07/25/17
07/25
06:28
07/25/17
06:28
Upgrade
Werner rating change  »

Werner upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

TNTR

Tintri

$6.95

0.16 (2.36%)

06:28
07/25/17
07/25
06:28
07/25/17
06:28
Initiation
Tintri initiated  »

Tintri initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BY

Byline Bancorp

$20.85

0.13 (0.63%)

06:28
07/25/17
07/25
06:28
07/25/17
06:28
Initiation
Byline Bancorp initiated  »

Byline Bancorp initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jul

LLY

Eli Lilly

$84.74

0.08 (0.09%)

06:26
07/25/17
07/25
06:26
07/25/17
06:26
Earnings
Eli Lilly reports Q2 EPS $1.11, consensus $1.05 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 11

    Sep

NCMGY

Newcrest Mining

$15.72

0.12 (0.77%)

06:26
07/25/17
07/25
06:26
07/25/17
06:26
Upgrade
Newcrest Mining rating change  »

Newcrest Mining upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPNC

Spectranetics

$38.50

0.05 (0.13%)

06:21
07/25/17
07/25
06:21
07/25/17
06:21
Downgrade
Spectranetics rating change  »

Spectranetics downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMP

Tompkins Financial

$78.41

-0.14 (-0.18%)

06:21
07/25/17
07/25
06:21
07/25/17
06:21
Upgrade
Tompkins Financial rating change  »

Tompkins Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNE

Sony

$40.61

-0.2 (-0.49%)

, AAPL

Apple

$152.09

1.82 (1.21%)

06:20
07/25/17
07/25
06:20
07/25/17
06:20
Periodicals
Sony restructures television production unit, WSJ reports »

Sony Pictures…

SNE

Sony

$40.61

-0.2 (-0.49%)

AAPL

Apple

$152.09

1.82 (1.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

LLY

Eli Lilly

$84.74

0.08 (0.09%)

, INCY

Incyte

$138.27

4.05 (3.02%)

06:20
07/25/17
07/25
06:20
07/25/17
06:20
Hot Stocks
Eli Lilly, Incyte resubmit baricitinib NDA to FDA »

Eli Lilly (LLY) and…

LLY

Eli Lilly

$84.74

0.08 (0.09%)

INCY

Incyte

$138.27

4.05 (3.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 01

    Aug

  • 11

    Sep

SSB

South State

$83.90

0.7 (0.84%)

06:19
07/25/17
07/25
06:19
07/25/17
06:19
Upgrade
South State rating change  »

South State upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 18

    Sep

BSRR

Sierra Bancorp

$24.15

0.34 (1.43%)

06:19
07/25/17
07/25
06:19
07/25/17
06:19
Upgrade
Sierra Bancorp rating change  »

Sierra Bancorp upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

BY

Byline Bancorp

$20.85

0.13 (0.63%)

06:17
07/25/17
07/25
06:17
07/25/17
06:17
Initiation
Byline Bancorp initiated  »

Byline Bancorp initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jul

GOOGL

Alphabet Class A

$998.31

4.47 (0.45%)

, GOOG

Alphabet

$980.34

7.42 (0.76%)

06:16
07/25/17
07/25
06:16
07/25/17
06:16
Recommendations
Alphabet Class A, Alphabet analyst commentary  »

Alphabet post-earnings…

GOOGL

Alphabet Class A

$998.31

4.47 (0.45%)

GOOG

Alphabet

$980.34

7.42 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LULU

lululemon

$62.02

0.08 (0.13%)

06:16
07/25/17
07/25
06:16
07/25/17
06:16
Downgrade
lululemon rating change  »

lululemon downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

WBMD

WebMD

$66.10

10.91 (19.77%)

06:14
07/25/17
07/25
06:14
07/25/17
06:14
Downgrade
WebMD rating change  »

WebMD downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBMD

WebMD

$66.10

10.91 (19.77%)

06:13
07/25/17
07/25
06:13
07/25/17
06:13
Downgrade
WebMD rating change  »

WebMD downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.